Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Piscitelli

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Pharmacotherapy|May 1, 1995
Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studiesD N Fish, S C Piscitelli, L H Danziger
Archives of Internal Medicine|June 1, 1992
Quinolone resistance: an alternative perspectiveD N Fish, S C Piscitelli, L H Danziger
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1992
Streptococcus milleri group: renewed interest in an elusive pathogenS C Piscitelli, J Shwed, P Schreckenberger, et al.
DICP : the Annals of Pharmacotherapy|September 1, 1990
Fluconazole: a new triazole antifungal agentM T Pasko, S C Piscitelli, A D Van Slooten
Antimicrobial Agents and Chemotherapy|January 20, 2000
Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbitsA H Groll, D Mickiene, S C Piscitelli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Supportive care during aldesleukin therapy for patients infected with human immunodeficiency virusC M Gabriel, J R Minor, S Vogel, et al.
Journal of Clinical Pharmacology|August 1, 1993
The disposition of doxorubicin on repeated dosingD A Rushing, S C Piscitelli, K A Rodvold, et al.
Klinische Padiatrie|September 23, 1998
Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancerA H Groll, F M Müller, S C Piscitelli, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides sppS L Pendland, S C Piscitelli, P C Schreckenberger, et al.
Clinical Pharmacokinetics|May 1, 1997
Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerationsS C Piscitelli, W G Reiss, W D Figg, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|May 1, 1995
Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studiesD N Fish, S C Piscitelli, L H Danziger
Archives of Internal Medicine|June 1, 1992
Quinolone resistance: an alternative perspectiveD N Fish, S C Piscitelli, L H Danziger
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1992
Streptococcus milleri group: renewed interest in an elusive pathogenS C Piscitelli, J Shwed, P Schreckenberger, et al.
DICP : the Annals of Pharmacotherapy|September 1, 1990
Fluconazole: a new triazole antifungal agentM T Pasko, S C Piscitelli, A D Van Slooten
Antimicrobial Agents and Chemotherapy|January 20, 2000
Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbitsA H Groll, D Mickiene, S C Piscitelli, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Supportive care during aldesleukin therapy for patients infected with human immunodeficiency virusC M Gabriel, J R Minor, S Vogel, et al.
Journal of Clinical Pharmacology|August 1, 1993
The disposition of doxorubicin on repeated dosingD A Rushing, S C Piscitelli, K A Rodvold, et al.
Klinische Padiatrie|September 23, 1998
Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancerA H Groll, F M Müller, S C Piscitelli, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides sppS L Pendland, S C Piscitelli, P C Schreckenberger, et al.
Clinical Pharmacokinetics|May 1, 1997
Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerationsS C Piscitelli, W G Reiss, W D Figg, et al.
Pageof 8